[Efficacy of different therapeutic principles in experimental retinal vessel occlusions].
D000818:Animals; D001241:Aspirin / Q000627:therapeutic use; D004195:Disease Models, Animal; D011464:Epoprostenol / Q000627:therapeutic use*; D053685:Laser Therapy; D005996:Nitroglycerin / Q000627:therapeutic use*; D011817:Rabbits; D012164:Retinal Diseases / Q000188:drug therapy*; D012171:Retinal Vessels; D014568:Urokinase-Type Plasminogen Activator / Q000627:therapeutic use
D011464:Epoprostenol; D014568:Urokinase-Type Plasminogen Activator; D005996:Nitroglycerin; D001241:Aspirin
Wirksamkeit unterschiedlicher Therapieprinzipien bei experimentellen Netzhautgefässverschlüssen.